ASTM D6355 Human Repeat Insult Patch Testing for Medical Gloves

ASTM D6355-07 test method evaluates the potential of glove materials to induce Type IV skin sensitization reactions (that is, allergic contact dermatitis) in humans. This test method is performed by individuals experienced in or under the supervision of those experienced in the use of good clinical practice procedures.

    Talk to an Expert
    ASTM D6355 Human Repeat Insult Patch Testing for Medical Gloves

    TRUSTED BY

    Precision-driven testing for dimensional accuracy and compliance

    • Overview
    • Scope, Applications, and Benefits
    • Test Process
    • Specifications
    • Instrumentation
    • Results and Deliverables

    Overview

    ASTM D6355 evaluates the potential of medical gloves to cause skin irritation or allergic reactions through Human Repeat Insult Patch Testing (HRIPT). It assesses both primary irritation and sensitization by exposing human subjects to controlled contact with glove materials under clinical supervision.

    This standard is critical for ensuring dermatological safety of medical gloves used in healthcare environments. It helps manufacturers identify irritants, reduce adverse skin reactions, and validate product compatibility for prolonged and repeated skin contact in sensitive applications.

    Scope, Applications, and Benefits

    Scope

    This standard is designed to evaluate skin compatibility, irritation potential, and sensitization risk of medical glove materials through controlled human exposure.

    • Assessment of primary skin irritation under repeated exposure
    • Evaluation of allergic sensitization potential (delayed hypersensitivity)
    • Conducted using human volunteers under clinical supervision
    • Applicable to natural rubber latex, nitrile, and synthetic glove materials
    • Used for safety validation and regulatory compliance of medical gloves
    • Focuses on real biological response rather than laboratory chemical properties

    Applications

    • Safety validation of medical examination gloves
    • Dermatological compatibility testing for skin-contact products
    • Identification of allergenic components in glove formulations
    • Product development for hypoallergenic glove materials
    • Pre-market regulatory testing for healthcare products
    • Risk assessment for occupational exposure in clinical environments

    Benefits

    • Reduces risk of skin irritation and allergic reactions
    • Improves glove safety for healthcare professionals and patients
    • Supports regulatory approval and compliance requirements
    • Enhances material formulation and product quality
    • Provides clinically relevant biological safety data
    • Builds confidence in long-term skin-contact applications

    Test Process

    Subject Screening

    Volunteers are selected and medically screened to ensure suitability for participation in the study.

    1

    Induction Phase

    Glove material is applied under occlusive patches repeatedly to initiate potential irritation or sensitization.

    2

    Rest Period

    A non-exposure phase allows the immune system to respond and develop any delayed reactions.

    3

    Challenge Phase

    Material is reapplied to confirm sensitization by observing any delayed allergic skin response.

    4

    Technical Specifications

    ParameterDetails
    Test populationSelected human volunteers meeting inclusion criteria
    Exposure methodOcclusive patch application for continuous contact
    Induction durationMultiple exposures over a defined period
    Challenge phaseReapplication after rest to confirm sensitization
    Scoring systemStandard dermatological evaluation for irritation
    Environmental conditionsTemperature and humidity controlled

    Instrumentation Used for Testing

    • Occlusive patch chambers
    • Dermatological scoring scales
    • Clinical observation tools
    • Data recording systems
    • Environmental control chamber
    • Timer and exposure tracking devices
    • Medical examination instruments

    Results and Deliverables

    • Irritation response score
    • Sensitization evaluation report
    • Clinical observation records
    • Pass/fail classification
    • Comparative control analysis
    • Complete HRIPT test report

    Why Choose Infinita Lab for ASTM D6355?

     At the core of this breadth is our network of 2,000+ accredited labs in the USA, offering access to over 10,000 test types. From advanced metrology (SEM, TEM, RBS, XPS) to mechanical, dielectric, environmental, and standardized ASTM/ISO testing, we give clients unmatched flexibility, specialization, and scale. You’re not limited by geography, facility, or methodology—Infinita connects you to the right testing, every time.

     

    Looking for a trusted partner to achieve your research goals? Schedule a meeting with us, send us a request, or call us at (888) 878-3090  to learn more about our services and how we can support you. Request a Quote

    Frequently Asked Questions

    ASTM D6355 uses repeated exposure followed by a challenge phase to detect delayed hypersensitivity reactions. This structured approach mimics real-world exposure, allowing accurate identification of allergens and sensitization risks that single-exposure tests cannot reveal.

    The challenge phase confirms whether sensitization has occurred after a rest period. It helps distinguish between simple irritation and immune-mediated allergic responses, ensuring that only truly biocompatible materials are approved for medical use.

    Factors include subject variability, environmental conditions, material composition, and application consistency. Proper control of these variables is essential to ensure accurate, reproducible, and meaningful test results that reflect true material behavior.

    Manufacturers can modify formulations, eliminate sensitizing chemicals like accelerators, and improve curing processes. These steps reduce allergen presence and enhance glove safety, making them suitable for sensitive users and healthcare applications.

    Limitations include variability among human subjects, time-consuming procedures, and the need for strict ethical controls. Despite these, it remains one of the most accurate methods for evaluating sensitization risk.

     Request a Quote

    Request a Quote

    Submit your material details and receive testing procedures, pricing, and turnaround time within 24 hours.



    • ddd
      Quick Turnaround and Hasslefree process
    • ddd
      Confidentiality Guarantee
    • ddd
      Free, No-obligation Consultation
    • ddd
      100% Customer Satisfaction
    Home / ASTM / ASTM D6355 Human Repeat Insult Patch Testing for Medical Gloves

    Discover more from Infinita Lab

    Subscribe now to keep reading and get access to the full archive.

    Continue reading

    ×

    Talk to an Expert

      Connect Instantly

      (888) 878-3090
      Ensure Quality with the Widest Network of Accredited Labs
      • ddd
        Quick Turnaround and Hasslefree process
      • ddd
        Confidentiality Guarantee
      • ddd
        Free, No-obligation Consultation
      • ddd
        100% Customer Satisfaction

        ddd

        Start Material Testing